Silver Book Fact

Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.

Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E. Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?. Journal of Heart Valve Disease. 2007; 16(4). https://www.medscape.com/medline/abstract/17702360

Nkomo V, Gardin J, Skelton T, Gottdiener J, et al. Burden of Valvular Heart Diseases: A population-based study. Lancet. September 2006; 368(9540). http://www.ncbi.nlm.nih.gov/pubmed/16980116

Reference

Title
Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?
Publication
Journal of Heart Valve Disease
Publication Date
2007
Authors
Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E
Volume & Issue
Volume 16, Issue 4
URL
Read Full Resource
Title
Burden of Valvular Heart Diseases: A population-based study
Publication
Lancet
Publication Date
September 2006
Authors
Nkomo V, Gardin J, Skelton T, Gottdiener J, et al.
Volume & Issue
Volume 368, Issue 9540
Pages
1005-11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Related Facts

  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Survival Rates Over 5 Years for Patients with Medically Managed Severe Aortic Stenosis
     
  • Aortic valve disease costs
    Aortic valve disease (AVD) (symptomatic and asymptomatic) costs the U.S. $10.2 billion in direct costs each year.  
  • Low detection rates for AS
    Prevalence estimates for AS are likely low. A U.K. population screening found previously undetected HVD in 1 in 2 adults ages 65+.  
  • Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient